维普期刊资源整合服务平台（V6.5）

35篇 您的检索式：作者名="CHIM AM"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population显示文摘	Wong GL Wong VW Chim AM		0，，02：	1
2	Trentment of patients with chronic hepatitis B who have failed previous antiviral treatment with pegylated interferon alphα-2a 显示文摘	Chan HL Wong WL Chim AM	2008	Antivir Ther2008，13，4：	1
3	Virological response to different combination regimes of peginterferon alpha-2b and lamivudine in hepatitis B antigen positive chronic hepatitis B显示文摘	Chan HL Wong VW Chim AM	2007	Antivir Ther2007，12，5：	1
4	Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chronic hepatitis B 显示文摘	Chan HL Wong VW Chim AM Chan HY Wong GL Sung JJ	2010	Aliment Pharmacol Ther2010，32，1112：	1
5	Treatment of patients with chronic hepatitis B who have failed previous antiviral treatment with pegylated interferon alpha2a (40 kda;PEGASYS)显示文摘	Chan HL Wong VW Chim AM		0，，：	1
6	Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population 显示文摘	Wong GL Wong VW Chim AM	2011	J Gastroenterol Hepatol2011，26，2：	1
7	Performance of the new MELD-Na score in predicting 3-month and 1-year mortality in Chinese patients with chronic hepatitis B显示文摘	Wong VW Chim AM Wong GL	2007	Liver Transpl2007，13，9：	1
8	Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chron- ic hepatitis B 显示文摘	Chan HL Wong VW Chim AM	2010	Aliment Pharmacol Ther2010，32，1112：	1
9	Performance of the new MELD-Na score in predicting 3-month and l-vear mortality in Chinese patients with chronic hepatitis B显示文摘	Wong VW Chim AM Wong GL	2007	Liver Transpl2007，13，9：	1
10	Virological response to different combination regimes of peginterferon alpha-2b and lamivudine in hepatitis B antigen positive chronic hepatitis B显示文摘	Chan HL Wong VW Chim AM	2007	Antivir Ther2007，12，5：	1
11	Virological response to different combination regimes of peginterferon alpha-2b and lamivudine in hepatitis B e antigen positive chronic hepatitis B 显示文摘	Chan HL Wong VW Chim AM	2007	Antivir Ther2007，12，5：	1
12	Prediction of off-treatment re- sponse to lamivudine by serum hepatitis B surface antigen quantifica- tion in hepatitis B e antigen-negative patients 显示文摘	Chan HL Wong GL Chim AM	2011	Antivir Ther2011，16，8：	1
13	Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chronic hepatitis B显示文摘	CHAN HL WONG VW CHIM AM	2010	Aliment Pharmacol Ther2010，32，1112：	1
14	Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chronic hepatitis B 显示文摘	CHAN HL WONG VW CHIM AM	2010	Aliment Pharmacol Ther2010，32，1112：	1
15	Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chronic hepatitis B显示文摘	Chan HL Wong VW Chim AM		Alimentary Pharmacology and Therapeutics0，，：	1
16	Factors associated with unreh- able liver stiffness measurement and its failure with transient elastogra- phy in the Chinese population 显示文摘	Wong GL Wong VW Chim AM	2011	J Gastroenterol Hepatol2011，26，2：	1
17	Prediction of off-treatment response to lamivudine by serum hepatitis B surface antigen quantification in hepatitis B e antigen-negative patients显示文摘	Chan HL Wong GL Chim AM		Antiviral Therapy0，，：	1
18	Treatment of patients with chronic hepatitis B who have failed previous antiviral treatment with pegylated interferon alpha 2a 显示文摘	Chan HL Wong VW Chim AM	2008	Antiviral therapy2008，13，：	1
19	Surrogate end points and long-term outcome in patients with chronic hepatitis B显示文摘	Wong VW Wong GL Chim AM	2009	Clin Gastroenterol Hepatol2009，，：	1
20	A comparative analysis of scaffold material modifications for load-bearing applications in bone tissue engineering显示文摘	Chim H Hutmacher DW Cheng AM	2006	Int J Oral Maxillofac Surg2006，35，10：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示